Language:

Results 21 - 40 of 113 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

1 Results 2 3 4 5

Refined by: Database: Coronavirus Research Database

Journal Title: Vaccines

Result Number	Material Type	Record Details and Options
21	Material Type: Article	Effectiveness of the BNT162b2 (Pfizer-BioNTech) Vaccine in Children and Adolescents: A Systematic Review and Meta-Analysis Vaccines (Basel), 2022-11, Vol.10 (11), p.1880 [Peer Reviewed Journal] COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10111880 ;PMID: 36366387 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
22	Material Type: Article	Internal and External Motivations and Risk Perception toward COVID-19 Vaccination in Adolescents in the U.S Vaccines (Basel), 2022-04, Vol.10 (5), p.697 [Peer Reviewed Journal] 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10050697 ;PMID: 35632453 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
23	Material Type: Article	Why It Is Important to Develop an Effective and Safe Pediatric COVID-19 Vaccine Vaccines (Basel), 2021-02, Vol.9 (2), p.127 [Peer Reviewed Journal] 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9020127 ;PMID: 33562619 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
24	Material Type: Article	"You Don't Know If It's the Truth or a Lie": Exploring Human Papillomavirus (HPV) Vaccine Hesitancy among Communities with Low HPV Vaccine Uptake in Northern California Vaccines (Basel), 2024-04, Vol.12 (4), p.372 [Peer Reviewed Journal] COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12040372 ;PMID: 38675754 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
25	Material Type: Article	Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review Vaccines (Basel), 2021-08, Vol.9 (8), p.869 [Peer Reviewed Journal] 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9080869 ;PMID: 34451994 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
26	Material Type: Article	Understanding Barriers to Human Papillomavirus Vaccination among Parents of 9-10-Year-Old Adolescents: A Qualitative Analysis Vaccines (Basel), 2024-02, Vol.12 (3), p.245 [Peer Reviewed Journal] COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 by the authors. 2024 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12030245 ;PMID: 38543879 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
27	Material Type: Article	Safety, Efficacy, and Immunogenicity of Varying Types of COVID-19 Vaccines in Children Younger Than 18 Years: An Update of Systematic Review and Meta-Analysis Vaccines (Basel), 2022-12, Vol.11 (1), p.87 [Peer Reviewed Journal] 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11010087 ;PMID: 36679932 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
28	Material Type: Article	Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study Vaccines (Basel), 2024-02, Vol.12 (2), p.210-210 [Peer Reviewed Journal] COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;2024 by the authors. 2024 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12020210 ;PMID: 38400193 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
29	Material Type: Article	"Every Time It Comes Time for Another Shot, It's a Re-Evaluation": A Qualitative Study of Intent to Receive COVID-19 Boosters among Parents Who Were Hesitant Adopters of the COVID-19 Vaccine Vaccines (Basel), 2024-02, Vol.12 (2), p.171 [Peer Reviewed Journal] COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 by the authors. 2024 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12020171 ;PMID: 38400154 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
30	Material Type: Article	Coping Strategies for Pertussis Resurgence Vaccines (Basel), 2023-04, Vol.11 (5), p.889 [Peer Reviewed Journal] COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11050889 ;PMID: 37242993 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
31	Material Type: Article	Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study Vaccines (Basel), 2022-05, Vol.10 (5), p.807 [Peer Reviewed Journal] 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10050807 ;PMID: 35632562 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
32	Material Type: Article	Adverse Events and Safety Profile of the COVID-19 Vaccines in Adolescents: Safety Monitoring for Adverse Events Using Real-World Data Vaccines (Basel), 2022-05, Vol.10 (5), p.744 [Peer Reviewed Journal] 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10050744 ;PMID: 35632500 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
33	Material Type: Article	The Role of Knowledge, Attitude, Confidence, and Sociodemographic Factors in COVID-19 Vaccination Adherence among Adolescents in Indonesia: A Nationwide Survey Vaccines (Basel), 2022-09, Vol.10 (9), p.1489 [Peer Reviewed Journal] COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10091489 ;PMID: 36146569 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
34	Material Type: Article	Adolescents' Opinions on COVID-19 Vaccine Hesitancy: Hints toward Enhancing Pandemic Preparedness in the Future Vaccines (Basel), 2023-05, Vol.11 (5), p.967 [Peer Reviewed Journal] COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11050967 ;PMID: 37243071 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
35	Material Type: Article	Epidemiology of Meningococcal Disease in Four South American Countries and Rationale of Vaccination in Adolescents from the Region: Position Paper of the Latin American Society of Pediatric Infectious Diseases (SLIPE) Vaccines (Basel), 2023-12, Vol.11 (12), p.1841 [Peer Reviewed Journal] COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11121841 ;PMID: 38140244 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
36	Material Type: Article	Assessing Barriers to Human Papillomavirus (HPV) Vaccination in At-Risk Rural Communities of Western North Carolina, United States Vaccines (Basel), 2023-11, Vol.11 (12), p.1785 [Peer Reviewed Journal] COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11121785 ;PMID: 38140189 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
37	Material Type: Article	Dose Intervals and Time since Final Dose on Changes in Metabolic Indices after COVID-19 Vaccination Vaccines (Basel), 2023-11, Vol.11 (12), p.1746 [Peer Reviewed Journal] COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11121746 ;PMID: 38140151 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
38	Material Type: Article	Attitudes toward COVID-19 and Other Vaccines: Comparing Parents to Other Adults, September 2022 Vaccines (Basel), 2023-11, Vol.11 (12), p.1735 [Peer Reviewed Journal] COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11121735 ;PMID: 38140140 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
39	Material Type: Article	Does Vaccination Protect against Human Papillomavirus-Related Cancers? Preliminary Findings from the United States National Health and Nutrition Examination Survey (2011-2018) Vaccines (Basel), 2022-12, Vol.10 (12), p.2113 [Peer Reviewed Journal] COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10122113 ;PMID: 36560523 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
40	Material Type: Article	Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Children: A Narrative Review Vaccines (Basel), 2023-10, Vol.11 (10), p.1594 [Peer Reviewed Journal] COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11101594 ;PMID: 37896996 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by